In news Recently, Guinea confirmed the first recorded case of Marburg virus death in West Africa.
About Marburg virus
Marburg virus disease (MVD) was formerly known as Marburg hemorrhagic fever.
Marburg virus disease is a highly virulent disease that causes hemorrhagic fever, with a fatality ratio of up to 88%.
It is in the same family as the virus that causes Ebola virus disease.
Two large outbreaks that occurred simultaneously in Marburg and Frankfurt in Germany, and in Belgrade, Serbia, in 1967, led to the initial recognition of the disease.
The outbreak was associated with laboratory work using African green monkeys (Cercopithecus aethiops) imported from Uganda.
Symptoms: Headache, vomiting blood, muscle pains and bleeding through various orifices. Many patients develop severe hemorrhagic signs within seven days. Case fatality rates have varied from 24% to 88% in past outbreaks depending on virus strain and case management.
Transmission
Rousettus aegyptiacus, fruit bats of the Pteropodidae family, are considered to be natural hosts of Marburg virus.
The Marburg virus is transmitted to people from fruit bats and spreads among humans through human-to-human transmission.
Once an individual is infected with the virus, Marburg can spread through human-to-human transmission via direct contact with the blood, secretions, organs or other bodily fluids of infected people, and with surfaces and materials contaminated with these fluids.
Treatment and vaccines: Currently there are no vaccines or antiviral treatments approved for MVD. However, supportive care rehydration with oral or intravenous fluids – and treatment of specific symptoms, improves survival.
The worst epidemic was in Angola in 2005, with 252 infections and a 90% death rate. This epidemic apparently spread through the reuse of contaminated transfusion equipment in a paediatric ward
